ANTHEM vs ZOTA: Stock Comparison

Anthem Biosciences Limited vs Zota Health Care Ltd

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Anthem Biosciences Limited is the larger company by market capitalisation. Anthem Biosciences Limited shows a higher ROE, a higher dividend yield and lower leverage, while Zota Health Care Ltd shows a lower P/E and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Anthem Biosciences Limited and Zota Health Care Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ANTHEM is more favourable on 9 of 13 scored metrics and ZOTA on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ANTHEM is the larger company
₹43,398 Cr vs ₹4,346 Cr
P/E Ratio
ZOTA has a lower P/E
-59.02x vs 75.11x
P/B Ratio
ZOTA has a lower P/B
6.29x vs 14.22x
EPS
ANTHEM has higher earnings per share
₹10.13 vs ₹-21.4
Dividend Yield
ANTHEM has a higher dividend yield
0.25% vs 0.08%
Revenue Growth (TTM YoY)
ZOTA has faster revenue growth
67.7% vs 26.4%
EPS Growth (TTM YoY)
ANTHEM has faster EPS growth
127.2% vs 0%
Qtr Sales Growth
ZOTA has stronger quarterly sales growth
67.8% vs 26.4%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricANTHEMZOTA
SectorHealthcareHealthcare
IndustryBiotechnologyPharmaceuticals

Price

MetricANTHEMZOTA
Live Price₹769.9₹1,258.4
Day Change-1.02%-2.93%
Volume2.43 L50,694
52-Week High₹873.5₹1,740
52-Week Low₹579.15₹1,026.2
Distance from 52W High-11.86%-27.68%

Valuation

MetricANTHEMZOTA
Market Cap₹43,398 Cr₹4,346 Cr
P/E Ratio75.11x-59.02x
P/B Ratio14.22x6.29x
EPS₹10.13₹-21.4
Book Value₹54.17₹200
Dividend Yield0.25%0.08%

Growth

MetricANTHEMZOTA
Revenue Growth (TTM YoY)26.4%67.7%
EPS Growth (TTM YoY)127.2%0%
Qtr Sales Growth26.4%67.8%
Qtr Profit Growth129%31.1%

Profitability & Leverage

MetricANTHEMZOTA
ROE22.3%-15%
ROCE30.4%-8.47%
Net Margin26.05%-13.98%
Operating Margin39.3%3.44%
Debt to Equity0.02x0.39x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricANTHEMZOTA
Promoter Holding71.42% 3.26 pp49.38% 1.26 pp
FII Holding2.58% 1.3 pp8.21% 0.12 pp
DII Holding13.48% 1.93 pp6.4% 0.82 pp
Public Holding12.53% 0.03 pp36% 1.94 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Anthem Biosciences Limited and Zota Health Care Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.